• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS EGFR TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS EGFR TEST V2; SOMATIC GENE MUTATION DETECTION SYSTEM Back to Search Results
Catalog Number 07248563190
Device Problems False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535); Output Problem (3005); Non Reproducible Results (4029)
Patient Problems No Consequences Or Impact To Patient (2199); Solid Tumour (4552); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/20/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation is ongoing.A follow-up report will be submitted upon the completion of the investigation.(b)(4).
 
Event Description
A customer from (b)(6) observed result discrepancies with ex20 ins when using two 5 micron ffpet sections for extraction for one patient sample.No harm is alleged.
 
Manufacturer Narrative
Roche received complaints from customers reporting the generation of false mutation detected results for the exon 20 insertion (ex20ins) mutation when using the cobas® egfr mutation test v2.During in-house testing using customer-provided ffpet samples, an ex20ins false mutation detected result was reproduced for one out of 8 ffpet samples, which was processed following the validated sample preparation method from the instructions for use.Although the majority of cases reported were from users using ffpet samples, the generation of false mutation detected ex20ins results with plasma specimens was reported in one case.A false mutation detected ex20ins result could lead to harm under specific scenarios.Consignees will be notified of the issue with instruction to follow the instructions for use for sample input requirements.Additionally, if an ex20ins mutation detected result is generated with the cobas® egfr mutation test v2, customers must confirm the result with another method (e.G., sequencing or other pcr-based tests).Correction to device code from non-reproducible results to false positive result (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS EGFR TEST V2
Type of Device
SOMATIC GENE MUTATION DETECTION SYSTEM
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
MDR Report Key11205737
MDR Text Key244857682
Report Number2243471-2021-00142
Device Sequence Number1
Product Code OWD
Combination Product (y/n)N
PMA/PMN Number
P120019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date 09/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number07248563190
Device Lot NumberF25967
Initial Date Manufacturer Received 12/21/2020
Initial Date FDA Received01/20/2021
Supplement Dates Manufacturer Received08/24/2021
Supplement Dates FDA Received09/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number2243471-08-24-2021-003-C
Patient Sequence Number1
-
-